MILabs’ preclinical imaging annual sales grows again by nearly 50%
UTRECHT, THE NETHERLANDS, April 6, 2018 MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%. “The dramatic increase in sales validates the design and functionality of our multimodal imaging platform and confirms [...]